Charles R. Marmar

Charles R. Marmar

Auto-generated profile, based on publicly available information

Charles R. Marmar

New York University, Grossman School of Medicine, New York City, NY, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
COChristian Otte
Christian Otte
SHStacey Hart
Stacey Hart
TNThomas C. Neylan
Thomas C. Neylan
CMCharles R. Marmar
Charles R. Marmar
KYKristine Yaffe
Kristine Yaffe
DMDavid C. Mohr
David C. Mohr

22 April 2019 in Depression and Anxiety
Verified
Journal Article
Open access
PDF file
CMCharles R. Marmar
Charles R. Marmar
ABAdam D. Brown
Adam D. Brown
MQMeng Qian
Meng Qian
ELEugene Laska
Eugene Laska
CSCarole Siegel
Carole Siegel
DVDimitra Vergyri
Dimitra Vergyri
Background The diagnosis of posttraumatic stress disorder (PTSD) is usually based on clinical interviews or self‐report measures. Both approaches are subject to under‐ and over‐reporting of symptoms. An objective test is lacking. We have developed a classifier of PTSD based on objective speech‐marker features that discriminate PTSD cases from controls. Methods Speech samples were obtained from warzone‐exposed veterans, 52 cases with PTSD and 77 controls, assessed with the Clinician‐Administered PTSD Scale. Individuals with major depressive disorder (MDD) were excluded. Audio recordings of clinical interviews were used to obtain 40,526 speech features which were input to a random forest (RF) algorithm. Results The selected RF used 18 speech features and the receiver operating characteristic curve had an area under the curve (AUC) of 0.954. At a probability of PTSD cut point of 0.423, Youden's index was 0.787, and overall correct classification rate was 89.1%. The probability of PTSD was higher for markers that indicated slower, more monotonous speech, less change in tonality, and less activation. Depression symptoms, alcohol use disorder, and TBI did not meet statistical tests to be considered confounders. Conclusions This study demonstrates that a speech‐based algorithm can objectively differentiate PTSD cases from controls. The RF classifier had a high AUC. Further validation in an independent sample and appraisal of the classifier to identify those with MDD only compared with those with PTSD comorbid with MDD is required.

1 March 2016 in Concussion
Verified
Journal Article
Open access
USUzma Samadani
Uzma Samadani
Meng LiMeng Li
Meng Li
MQMeng Qian
Meng Qian
ELEugene Laska
Eugene Laska
RRRobert Ritlop
Robert Ritlop
CMCharles Marmar
Charles Marmar
Object: The purpose of the current study is to determine the sensitivity and specificity of an eye tracking method as a classifier for identifying concussion. Methods: Brain injured and control subjects prospectively underwent both eye tracking and Sport Concussion Assessment Tool 3. The results of eye tracking biomarker based classifier models were then validated against a dataset of individuals not used in building a model. The area under the curve (AUC) of receiver operating characteristics was examined. Results: An optimal classifier based on best subset had an AUC of 0.878, and a cross-validated AUC of 0.852 in CT- subjects and an AUC of 0.831 in a validation dataset. The optimal misclassification rate in an external dataset (n = 254) was 13%. Conclusion: If one defines concussion based on history, examination, radiographic and Sport Concussion Assessment Tool 3 criteria, it is possible to generate an eye tracking based biomarker that enables detection of concussion with reasonably high sensitivity and specificity.

7 November 2024 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
ZWZhenfu Wen
Zhenfu Wen
MHMira Z. Hammoud
Mira Z. Hammoud
CSCarole E. Siegel
Carole E. Siegel
ELEugene M. Laska
Eugene M. Laska
DADuna Abu-Amara
Duna Abu-Amara
CMCharles R. Marmar
Charles R. Marmar
Neuroimaging-based subtyping is increasingly used to explain heterogeneity in psychiatric disorders. However, the clinical utility of these subtyping efforts remains unclear, and replication has been challenging. Here we examined how the choice of neuroimaging measures influences the derivation of neuro-subtypes and the consequences for clinical delineation. On a clinically heterogeneous dataset (total n = 566) that included controls (n = 268) and cases (n = 298) of psychiatric conditions, including individuals diagnosed with post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), and comorbidity of both (PTSD&TBI), we identified neuro-subtypes among the cases using either structural, resting-state, or task-based measures. The neuro-subtypes for each modality had high internal validity but did not significantly differ in their clinical and cognitive profiles. We further show that the choice of neuroimaging measures for subtyping substantially impacts the identification of neuro-subtypes, leading to low concordance across subtyping solutions. Similar variability in neuro-subtyping was found in an independent dataset (n = 1642) comprised of major depression disorder (MDD, n = 848) and controls (n = 794). Our results suggest that the highly anticipated relationships between neuro-subtypes and clinical features may be difficult to discover.

Verified
Journal Article
Open access
PDF file
BMBurook Misganaw
Burook Misganaw
RYRuoting Yang
Ruoting Yang
AGAarti Gautam
Aarti Gautam
SMSeid Y. Muhie
Seid Y. Muhie
SMSynthia H. Mellon
Synthia H. Mellon
RHRasha Hammamieh
Rasha Hammamieh
Post-traumatic stress disorder (PTSD) is a highly debilitating psychiatric disorder that can be triggered by exposure to extreme trauma. Even if PTSD is primarily a psychiatric condition, it is also characterized by adverse somatic comorbidities. One illness commonly co-occurring with PTSD is Metabolic syndrome (MetS), which is defined by a set of health risk/resilience factors including obesity, elevated blood pressure, lower high-density lipoprotein cholesterol, higher low-density lipoprotein cholesterol, higher triglycerides, higher fasting blood glucose and insulin resistance. Here, phenotypic association between PTSD and components of MetS are tested on a military veteran cohort comprising chronic PTSD presentation (n = 310, 47% cases, 83% male). Consistent with previous observations, we found significant phenotypic correlation between the various components of MetS and PTSD severity scores. To examine if this observed symptom correlations stem from a shared genetic background, we conducted genetic correlation analysis using summary statistics data from large-scale genetic studies. Our results show robust positive genetic correlation between PTSD and MetS (rg[SE] = 0.33 [0.056], p = 4.74E-09), and obesity-related components of MetS (rg = 0.25, SE = 0.05, p = 6.4E-08). Prioritizing genomic regions with larger local genetic correlation implicate three significant loci. Overall, these findings show significant genetic overlap between PTSD and MetS, which may in part account for the markedly increased occurrence of MetS among PTSD patients.

6 March 2006 in Journal of Trauma & Dissociation
Verified
Journal Article
Closed access
NPNnamdi Pole
Nnamdi Pole
ECEvelyn Cumberbatch
Evelyn Cumberbatch
WTWendy M. Taylor
Wendy M. Taylor
TMThomas Metzler
Thomas Metzler
CMCharles R. Marmar
Charles R. Marmar
TNThomas C. Neylan
Thomas C. Neylan
Peritraumatic dissociation (PD) is one of the best predictors of posttraumatic stress disorder (PTSD). In this pilot study, we examined cardiovascular psychophysiology and negative emotion...